Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6199822 | Ophthalmology | 2016 | 7 Pages |
Abstract
Many corneal specialists currently are uncertain about the risk benefit associated with the use of topical corticosteroids for the management of inflammatory complications of AK. The evidence from this study gives clinicians and patients reassurance that the potential benefits of topical corticosteroid therapy, for treating pain and discomfort, are not associated with worse outcomes when initiated after starting modern AAT. Other potential benefits, in terms of resolution of inflammatory complications, will not be demonstrated without a carefully designed randomized clinical trial.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Nicole PhD, B.Optom, Dana PhD, FRANZCO, Stephanie L. PhD, FRANZCO, Darwin C. FRCOphth, MSc(Epidem), John K.G. DM, FRCOphth,